Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows Used in Operating Activities    
Net loss $ (8,152) $ (7,208)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,580 2,813
Interest accretion 248 312
Provision for bad debt (6)
Amortization of debt issuance costs 117
Mark to market on derivatives 61
Reversal of severance accrual (2,034)
Reversal of DOJ accrual (350)
Mark to market on warrants 259 401
Loss on extinguishment of debt 4,278
Stock-based compensation, consulting agreements 174 216
Stock-based compensation 1,390 477
Change in fair value of contingent consideration (5,776)
Other changes in assets and liabilities:    
Increase in accounts receivable (2,703) (588)
(Increase) decrease in other current assets (174) 162
Decrease in other long-term assets 220
Increase (decrease) in accounts payable 674 (2,208)
Decrease in accrued salaries and bonus (248) (1,805)
Decrease in other accrued expenses (680) (2,210)
Increase (decrease) in other long-term liabilities 182 (106)
Net cash used in operating activities (6,800) (12,884)
Cash Flows Used in Investing Activities    
Purchase of property and equipment (388) (29)
Net cash used in investing activities (388) (29)
Cash Flows Used in Financing Activities    
Issuance of common stock, net of expenses 24,042
Cash paid for repurchase of restricted shares (9) (28)
Net cash (used in) provided by financing activities (9) 24,014
Net (decrease) increase in cash and cash equivalents (7,197) 11,101
Cash and cash equivalents - beginning 15,199 602
Cash and cash equivalents - ending $ 8,002 $ 11,703